Literature DB >> 16299134

Comparison of optical coherence tomography models OCT1 and Stratus OCT for macular retinal thickness measurement.

V Pierre-Kahn1, R Tadayoni, B Haouchine, P Massin, A Gaudric.   

Abstract

AIMS: To compare the values measured for retinal macular thickness with the first and last generations of the optical coherence tomograph (OCT1 and Stratus OCT, Zeiss, Humphrey Division).
METHODS: This was a cohort study. 59 eyes were examined: 17 had a normal macula and 42 had a diabetic macular oedema. In each eye, mean retinal thickness (RT) was measured automatically in the nine macular Early Treatment Diabetic Retinopathy Study areas and at the foveal centre, using OCT1 and Stratus OCT. The paired mean RT values for each area and the type and proportion of artefacts were compared.
RESULTS: Of the 590 automatic measurements, 505 had no artefact, either with OCT1 or Stratus OCT. The mean difference between the OCT1 and Stratus OCT measurements was 25 (SD 26.2) microm (p<0.0001). With Stratus OCT, RT values were significantly higher, by 8.1% (7.8%), than with OCT1. Artefacts were only observed in cases of diabetic macular oedema and were significantly more frequent with OCT1 than Stratus OCT (10.5% versus 4.4, p<0.0001).
CONCLUSION: The macular retinal thickness values measured with Stratus OCT were significantly higher than those measured with OCT1. Stratus OCT has the advantage of producing fewer artefacts than OCT1 in pathological cases.

Entities:  

Mesh:

Year:  2005        PMID: 16299134      PMCID: PMC1772971          DOI: 10.1136/bjo.2005.069815

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  7 in total

1.  Enhanced visualization of macular pathology with the use of ultrahigh-resolution optical coherence tomography.

Authors:  Wolfgang Drexler; Harald Sattmann; Boris Hermann; Tony H Ko; Michael Stur; Angelika Unterhuber; Christoph Scholda; Oliver Findl; Matthias Wirtitsch; James G Fujimoto; Adolf F Fercher
Journal:  Arch Ophthalmol       Date:  2003-05

2.  Reproducibility of retinal thickness measurements in normal eyes using optical coherence tomography.

Authors:  M Baumann; R C Gentile; J M Liebmann; R Ritch
Journal:  Ophthalmic Surg Lasers       Date:  1998-04

3.  Topography of diabetic macular edema with optical coherence tomography.

Authors:  M R Hee; C A Puliafito; J S Duker; E Reichel; J G Coker; J R Wilkins; J S Schuman; E A Swanson; J G Fujimoto
Journal:  Ophthalmology       Date:  1998-02       Impact factor: 12.079

4.  Reproducibility of retinal mapping using optical coherence tomography.

Authors:  P Massin; E Vicaut; B Haouchine; A Erginay; M Paques; A Gaudric
Journal:  Arch Ophthalmol       Date:  2001-08

5.  Patterns of diabetic macular edema with optical coherence tomography.

Authors:  T Otani; S Kishi; Y Maruyama
Journal:  Am J Ophthalmol       Date:  1999-06       Impact factor: 5.258

6.  Retinal thickness in healthy and diabetic subjects measured using optical coherence tomography mapping software.

Authors:  P Massin; A Erginay; B Haouchine; A Ben Mehidi; M Paques; A Gaudric
Journal:  Eur J Ophthalmol       Date:  2002 Mar-Apr       Impact factor: 2.597

7.  Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group.

Authors: 
Journal:  Arch Ophthalmol       Date:  1985-12
  7 in total
  13 in total

1.  Optical coherence tomography as a potential readout in clinical trials.

Authors:  Benjamin M Greenberg; Elliot Frohman
Journal:  Ther Adv Neurol Disord       Date:  2010-05       Impact factor: 6.570

Review 2.  A reference standard for the measurement of macular oedema.

Authors:  K A Goatman
Journal:  Br J Ophthalmol       Date:  2006-09       Impact factor: 4.638

Review 3.  Ultra high-resolution anterior segment optical coherence tomography in the diagnosis and management of ocular surface squamous neoplasia.

Authors:  Benjamin J Thomas; Anat Galor; Afshan A Nanji; Fouad El Sayyad; Jianhua Wang; Sander R Dubovy; Madhura G Joag; Carol L Karp
Journal:  Ocul Surf       Date:  2013-11-09       Impact factor: 5.033

4.  Fourier-domain optical coherence tomography and adaptive optics reveal nerve fiber layer loss and photoreceptor changes in a patient with optic nerve drusen.

Authors:  Stacey S Choi; Robert J Zawadzki; Mark A Greiner; John S Werner; John L Keltner
Journal:  J Neuroophthalmol       Date:  2008-06       Impact factor: 3.042

5.  Comparison of retinal nerve fiber layer measurements using time domain and spectral domain optical coherent tomography.

Authors:  O'Rese J Knight; Robert T Chang; William J Feuer; Donald L Budenz
Journal:  Ophthalmology       Date:  2009-04-22       Impact factor: 12.079

6.  Macular thickness measurements in normal eyes with time-domain and Fourier-domain optical coherence tomography.

Authors:  Jingjing Huang; Xing Liu; Ziqiang Wu; Hui Xiao; Laurie Dustin; Srinivas Sadda
Journal:  Retina       Date:  2009 Jul-Aug       Impact factor: 4.256

7.  Comparison of central macular thickness measured by three OCT models and study of interoperator variability.

Authors:  Zaïnab Bentaleb-Machkour; Eléonore Jouffroy; Muriel Rabilloud; Jean-Daniel Grange; Laurent Kodjikian
Journal:  ScientificWorldJournal       Date:  2012-08-22

8.  Comparison of retinal nerve fiber layer thickness measurements in healthy subjects using fourier and time domain optical coherence tomography.

Authors:  Isabel Pinilla; Elena Garcia-Martin; Miriam Idoipe; Eva Sancho; Isabel Fuertes
Journal:  J Ophthalmol       Date:  2012-05-29       Impact factor: 1.909

9.  Spectral domain optical coherence tomography in children: normative data and biometric correlations.

Authors:  Christiane Al-Haddad; Anita Barikian; Mahmoud Jaroudi; Vicky Massoud; Hani Tamim; Baha' Noureddin
Journal:  BMC Ophthalmol       Date:  2014-04-22       Impact factor: 2.209

10.  Comparison study of OCT, HRT and VF findings among normal controls and patients with pseudoexfoliation, with or without increased IOP.

Authors:  Fryni Riga; Ilias Georgalas; Panagiotis Tsikripis; Dimitrios Papaconstantinou
Journal:  Clin Ophthalmol       Date:  2014-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.